Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1/2 1

Status

Unknown 2Completed 2

Sponsor Class

OTHER 8NIH 4NETWORK 1

Study Type

Interventional 4

Sponsor

Cancer Type

Other hematologic neoplasm 6Lymphoid 5Thoracic 4Plasma cell 2Head & Neck 2Dermatologic 2Sarcoma 1Other neoplasm 1Myeloid 1Genitourinary 1Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 278Lung Neoplasms 257Small Cell Lung Carcinoma 82Breast Neoplasms 59Mesothelioma, Malignant 49Adenocarcinoma of Lung 43Pancreatic Neoplasms 37Colonic Neoplasms 37Neoplasms 32Prostatic Neoplasms 30Ovarian Neoplasms 28Esophageal Neoplasms 26Neoplasm Metastasis 24Mesothelioma 24Melanoma 24Adenocarcinoma, Bronchiolo-Alveolar 24Stomach Neoplasms 22Colorectal Neoplasms 22Carcinoma, Renal Cell 22Rectal Neoplasms 20Urinary Bladder Neoplasms 18Uterine Cervical Neoplasms 17Squamous Cell Carcinoma of Head and Neck 17Carcinoma, Hepatocellular 17Brain Neoplasms 17Lymphoma, Non-Hodgkin 16Carcinoma, Ovarian Epithelial 16Thymoma 15Salivary Gland Neoplasms 15Lymphoma 15

Interventions

Radiotherapy 3Amifostine 3Paclitaxel 2Cisplatin 2Carboplatin 2Taxes 1Radiation 1Etoposide 1Docetaxel 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
NIH × Drug-Related Side Effects and Adverse Reactions × Thoracic × Clear all
NCT00003583 2013-12-04

Amifostine to Prevent Side Effects in Patients Who Are Receiving Chemotherapy and Radiation Therapy for Limited-Stage Small Cell Lung Cancer

National Cancer Institute (NCI)

Phase 2 Unknown
20 enrolled
Thoracic

Lung Neoplasms, Radiation Injuries, Drug-Related Side Effects and Adverse Reactions

NCT00004264 2013-12-04

Docetaxel, Cisplatin, and Amifostine in Treating Patients With Advanced Non-small Cell Lung Cancer

National Cancer Institute (NCI)

Phase 1/2 Unknown
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT00003089 2013-07-10

Chemotherapy, Amifostine, and Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer

National Cancer Institute (NCI)

Phase 2 Completed
Thoracic

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT00387374 2013-01-17

Radiation Therapy, Bevacizumab, Paclitaxel, and Carboplatin in Treating Patients With Unresectable Stage IIIB or Stage IV Non-Small Cell Lung Cancer at High Risk for Hemoptysis Caused by Bevacizumab

National Cancer Institute (NCI)

Phase 2 Completed
72 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Hemoptysis, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡